Ralph Brandenberger
Technik-/Wissenschafts-/F&E-Leiter bei NKARTA, INC.
Vermögen: 541 455 $ am 31.05.2024
Profil
Ralph Brandenberger is currently the Chief Technical Officer at Nkarta, Inc. He previously worked as the Director-Process Sciences at Geron Corp from 2001 to 2012, the Senior Director-Process Development at Neurona Therapeutics, Inc. from 2016 to 2018, and the Head-Technical Operations at Baxalta US, Inc. from 2012 to 2016.
Dr. Brandenberger holds graduate and doctorate degrees from the University of Basel.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NKARTA, INC.
0,11% | 18.06.2024 | 79 743 ( 0,11% ) | 541 455 $ | 31.05.2024 |
Aktive Positionen von Ralph Brandenberger
| Unternehmen | Position | Beginn |
|---|---|---|
| NKARTA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
Ehemalige bekannte Positionen von Ralph Brandenberger
| Unternehmen | Position | Ende |
|---|---|---|
Neurona Therapeutics, Inc.
 Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.03.2018 |
Baxalta US, Inc.
 Baxalta US, Inc. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Baxalta US, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The company is based in Deerfield, IL. | Corporate Officer/Principal | 01.04.2016 |
| GERON CORPORATION | Corporate Officer/Principal | 01.06.2012 |
Ausbildung von Ralph Brandenberger
| University of Basel | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NKARTA, INC. | Health Technology |
| GERON CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Neurona Therapeutics, Inc.
Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Health Technology |
Baxalta US, Inc.
Baxalta US, Inc. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Baxalta US, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The company is based in Deerfield, IL. | Health Technology |
